These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36469184)

  • 1. Fracture distribution in postmenopausal women: a FRISBEE sub-study.
    Aude M; Jean-Jacques B; Laura I; Felicia B; Alexia C; Serge R; Mureille S; Pierre B; Florence B
    Arch Osteoporos; 2022 Dec; 18(1):3. PubMed ID: 36469184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MOF/Hip Fracture Ratio in a Belgian Cohort of Post-menopausal Women (FRISBEE): Potential Impact on the FRAX® Score.
    Mugisha A; Bergmann P; Kinnard V; Iconaru L; Baleanu F; Charles A; Surquin M; Rozenberg S; Benoit F; Body JJ
    Calcif Tissue Int; 2021 Dec; 109(6):600-604. PubMed ID: 34159447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. External validation of FRISBEE 5-year fracture prediction models: a registry-based cohort study.
    Agarwal A; Baleanu F; Moreau M; Charles A; Iconaru L; Surquin M; Benoit F; Paesmans M; Karmali R; Bergmann P; Body JJ; Leslie WD
    Arch Osteoporos; 2022 Dec; 18(1):13. PubMed ID: 36564674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of osteopenic women at high risk of fracture: the OFELY study.
    Sornay-Rendu E; Munoz F; Garnero P; Duboeuf F; Delmas PD
    J Bone Miner Res; 2005 Oct; 20(10):1813-9. PubMed ID: 16160738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive value of low BMD for 1-year fracture outcomes is similar for postmenopausal women ages 50-64 and 65 and Older: results from the National Osteoporosis Risk Assessment (NORA).
    Siris ES; Brenneman SK; Miller PD; Barrett-Connor E; Chen YT; Sherwood LM; Abbott TA
    J Bone Miner Res; 2004 Aug; 19(8):1215-20. PubMed ID: 15231007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rate of forearm bone loss is associated with an increased risk of fracture independently of bone mass in postmenopausal women: the OFELY study.
    Sornay-Rendu E; Munoz F; Duboeuf F; Delmas PD
    J Bone Miner Res; 2005 Nov; 20(11):1929-35. PubMed ID: 16234965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fracture Rates and Bone Density Among Postmenopausal Veteran and Non-Veteran Women From the Women's Health Initiative.
    LaFleur J; Rillamas-Sun E; Colón-Emeric CS; Knippenberg KA; Ensrud KE; Gray SL; Cauley JA; LaCroix AZ
    Gerontologist; 2016 Feb; 56 Suppl 1(Suppl 1):S78-90. PubMed ID: 26768394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fragility Fractures in Postmenopausal Women: Development of 5-Year Prediction Models Using the FRISBEE Study.
    Baleanu F; Moreau M; Charles A; Iconaru L; Karmali R; Surquin M; Benoit F; Mugisha A; Paesmans M; Rubinstein M; Rozenberg S; Bergmann P; Body JJ
    J Clin Endocrinol Metab; 2022 May; 107(6):e2438-e2448. PubMed ID: 35176768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of an Imminent Fracture After an Index Fracture - Models Derived From the Frisbee Cohort.
    Iconaru L; Charles A; Baleanu F; Surquin M; Benoit F; Mugisha A; Moreau M; Paesmans M; Karmali R; Rubinstein M; Rozenberg S; Body JJ; Bergmann P
    J Bone Miner Res; 2022 Jan; 37(1):59-67. PubMed ID: 34490908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study.
    McClung MR; O'Donoghue ML; Papapoulos SE; Bone H; Langdahl B; Saag KG; Reid IR; Kiel DP; Cavallari I; Bonaca MP; Wiviott SD; de Villiers T; Ling X; Lippuner K; Nakamura T; Reginster JY; Rodriguez-Portales JA; Roux C; Zanchetta J; Zerbini CAF; Park JG; Im K; Cange A; Grip LT; Heyden N; DaSilva C; Cohn D; Massaad R; Scott BB; Verbruggen N; Gurner D; Miller DL; Blair ML; Polis AB; Stoch SA; Santora A; Lombardi A; Leung AT; Kaufman KD; Sabatine MS;
    Lancet Diabetes Endocrinol; 2019 Dec; 7(12):899-911. PubMed ID: 31676222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Independent predictors of all osteoporosis-related fractures in healthy postmenopausal women: the OFELY study.
    Albrand G; Munoz F; Sornay-Rendu E; DuBoeuf F; Delmas PD
    Bone; 2003 Jan; 32(1):78-85. PubMed ID: 12584039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incident Fracture Risk in Type 2 Diabetic Postmenopausal Women in Mainland China: Peking Vertebral Fracture Study.
    Jiajue R; Qi X; Jiang Y; Wang Q; Wang W; Pei Y; Wang X; Huang W; Zheng X; Ning Z; Wang O; Li M; Xing X; Yu W; Xu L; Xia W
    Calcif Tissue Int; 2019 Nov; 105(5):466-475. PubMed ID: 31511960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Underevaluation of fractures by self-report: an analysis from the FRISBEE cohort.
    Baleanu F; Moreau M; Kinnard V; Iconaru L; Karmali R; Rozenberg S; Rubinstein M; Paesmans M; Bergmann P; Body JJ
    Arch Osteoporos; 2020 Apr; 15(1):61. PubMed ID: 32323006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serial Bone Density Measurement and Incident Fracture Risk Discrimination in Postmenopausal Women.
    Crandall CJ; Larson J; Wright NC; Laddu D; Stefanick ML; Kaunitz AM; Watts NB; Wactawski-Wende J; Womack CR; Johnson KC; Carbone LD; Jackson RD; Ensrud KE
    JAMA Intern Med; 2020 Sep; 180(9):1232-1240. PubMed ID: 32730575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disc space narrowing is associated with an increased vertebral fracture risk in postmenopausal women: the OFELY Study.
    Sornay-Rendu E; Munoz F; Duboeuf F; Delmas PD;
    J Bone Miner Res; 2004 Dec; 19(12):1994-9. PubMed ID: 15537442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of incidence of osteoporotic fractures in the female Spanish population older than 50.
    Naves M; Díaz-López JB; Gómez C; Rodríguez-Rebollar A; Cannata-Andía JB
    Osteoporos Int; 2005 Dec; 16(12):2013-7. PubMed ID: 16091836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vertebral fracture in postmenopausal Chinese women: a population-based study.
    Cui L; Chen L; Xia W; Jiang Y; Cui L; Huang W; Wang W; Wang X; Pei Y; Zheng X; Wang Q; Ning Z; Li M; Wang O; Xing X; Lin Q; Yu W; Weng X; Xu L; Cummings SR
    Osteoporos Int; 2017 Sep; 28(9):2583-2590. PubMed ID: 28560474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of age and bone mineral density on the absolute, excess, and relative risk of fracture in postmenopausal women aged 50-99: results from the National Osteoporosis Risk Assessment (NORA).
    Siris ES; Brenneman SK; Barrett-Connor E; Miller PD; Sajjan S; Berger ML; Chen YT
    Osteoporos Int; 2006; 17(4):565-74. PubMed ID: 16392027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are there specific clinical risk factors for the occurrence of multiple fractures? The FRISBEE study.
    Charles A; Iconaru L; Baleanu F; Benoit F; Surquin M; Mugisha A; Bergmann P; Body JJ
    Osteoporos Int; 2023 Mar; 34(3):501-506. PubMed ID: 36598524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalent vertebral fractures predict subsequent radiographic vertebral fractures in postmenopausal Korean women receiving antiresorptive agent.
    Kim SH; Choi HS; Rhee Y; Kim KJ; Lim SK
    Osteoporos Int; 2011 Mar; 22(3):781-7. PubMed ID: 20533028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.